These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21211107)

  • 1. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
    Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
    Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
    Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
    Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
    Wegener N; Koch M
    Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
    Schneider M; Drews E; Koch M
    Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Tanganelli S; Finetti S; Mazzoni E; Trabace L; Steardo L; Cuomo V; Ferraro L
    Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
    Leweke FM; Schneider M
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
    Schneider M; Schömig E; Leweke FM
    Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol.
    Pava MJ; Blake EM; Green ST; Mizroch BJ; Mulholland PJ; Woodward JJ
    Psychopharmacology (Berl); 2012 Jan; 219(1):137-47. PubMed ID: 21701813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures.
    Lemos JI; Takahashi RN; Morato GS
    Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP).
    Marszalek-Grabska M; Smaga I; Surowka P; Grochecki P; Slowik T; Filip M; Kotlinska JH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
    Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
    López-Moreno JA; González-Cuevas G; Rodríguez de Fonseca F; Navarro M
    J Neurosci; 2004 Sep; 24(38):8245-52. PubMed ID: 15385608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB
    Kirson D; Oleata CS; Parsons LH; Ciccocioppo R; Roberto M
    Addict Biol; 2018 Mar; 23(2):676-688. PubMed ID: 28656627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.